Načítá se...
Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma
INTRODUCTION: Nectin-4 is a tumor-associated antigen overexpressed in urothelial carcinoma and several other malignancies. It has emerged as a compelling target for novel tumor-directed therapies, particularly as a component of antibody-drug conjugates (ADCs), a growing class of anti-cancer therapeu...
Uloženo v:
| Vydáno v: | Expert Opin Biol Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8224177/ https://ncbi.nlm.nih.gov/pubmed/34030536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2021.1929168 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|